Sign in

CIK 0001512762

  • Accelerated filer
  • Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273615821
Phone
+1 650-649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 4 Open-market sale Chief Scientific Officer sold 4,250 shares at $16.89 ($71,775)
  2. 4 Open-market sale Chief Scientific Officer sold 4,250 shares at $18.67 ($79,360)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4/A Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4/A Open-market sale Director sold 6,372 shares at $33.50 ($213,475)
  12. 4 Open-market sale Chief Technical Officer sold 12,000 shares at $20.00 ($240,000)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market sale Chief Technical Officer sold 21,493 shares at an average $26.89 ($578,038)
  19. 4/A Derivatives Options or other derivatives
  20. 4 Open-market sale Chief Scientific Officer sold 4,250 shares at an average $19.20 ($81,592)

Page 16 of 20 · 399 filings